about
Inflammation and the neural diathesis-stress hypothesis of schizophrenia: a reconceptualizationβ-Adrenoceptor blockade modulates fusiform gyrus activity to black versus white facesTreatment resistant or resistant to treatment? Antipsychotic plasma levels in patients with poorly controlled psychotic symptomsGlutamate and dopamine in schizophrenia: an update for the 21st centuryThe practical management of refractory schizophrenia--the Maudsley Treatment REview and Assessment Team service approach.Brain-imaging studies of treatment-resistant schizophrenia: a systematic review.The Role of Genes, Stress, and Dopamine in the Development of Schizophrenia.Opposing neural effects of naltrexone on food reward and aversion: implications for the treatment of obesity.Community treatment orders for patients with psychosis.Antipsychotic plasma levels in the assessment of poor treatment response in schizophrenia.Amygdala reactivity in ethnic minorities and its relationship to the social environment: an fMRI study.Defining the Locus of Dopaminergic Dysfunction in Schizophrenia: A Meta-analysis and Test of the Mesolimbic Hypothesis.The diagnosis debate.Treatment-Resistant Schizophrenia in a Patient With 17q12 Duplication.A Meta-analysis of Immune Parameters, Variability, and Assessment of Modal Distribution in Psychosis and Test of the Immune Subgroup HypothesisCorrection to: Is psychosis a multisystem disorder? A meta-review of central nervous system, immune, cardiometabolic, and endocrine alterations in first-episode psychosis and perspective on potential modelsMesolimbic Dopamine Function Is Related to Salience Network Connectivity: An Integrative Positron Emission Tomography and Magnetic Resonance StudyThe relationship between cortical glutamate and striatal dopamine in first-episode psychosis: a cross-sectional multimodal PET and magnetic resonance spectroscopy imaging studyLetter to the EditorThe Relationship Between Dopamine Synthesis Capacity and Release: Implications for PsychosisSchizophrenia, Dopamine and the Striatum: From Biology to SymptomsThe effects of psychosocial stress on dopaminergic function and the acute stress responseTask-induced functional brain connectivity mediates the relationship between striatal D2/3 receptors and working memoryIs psychosis a multisystem disorder? A meta-review of central nervous system, immune, cardiometabolic, and endocrine alterations in first-episode psychosis and perspective on potential modelsSleep and Circadian Rhythm Disturbance in Remitted Schizophrenia and Bipolar Disorder: A Systematic Review and Meta-analysisChronic psychosocial stressors are associated with alterations in salience processing and corticostriatal connectivityGlutamatergic and dopaminergic function and the relationship to outcome in people at clinical high risk of psychosis: a multi-modal PET-magnetic resonance brain imaging studyGlutamatergic function in a genetic high-risk group for psychosis: A proton magnetic resonance spectroscopy study in individuals with 22q11.2 deletionSchizophrenia-An OverviewThe relationship between childhood trauma, dopamine release and dexamphetamine-induced positive psychotic symptoms: a [11C]-(+)-PHNO PET studyHeterogeneity and efficacy of antipsychotic treatment for schizophrenia with or without treatment resistance: a meta-analysisGlutamate levels in the anterior cingulate cortex in un-medicated first episode psychosis: a proton magnetic resonance spectroscopy studyAntipsychotics: Mechanisms underlying clinical response and side-effects and novel treatment approaches based on pathophysiologyAltered glutamatergic response and functional connectivity in treatment resistant schizophrenia: the effect of riluzole and therapeutic implicationsComparative effects of 18 antipsychotics on metabolic function in patients with schizophrenia, predictors of metabolic dysregulation, and association with psychopathology: a systematic review and network meta-analysisThe effects of cannabinoid 1 receptor compounds on memory: a meta-analysis and systematic review across speciesDopamine and glutamate in schizophrenia: biology, symptoms and treatmentMagnitude and heterogeneity of brain structural abnormalities in 22q11.2 deletion syndrome: a meta-analysisThe efficacy and heterogeneity of antipsychotic response in schizophrenia: A meta-analysisPrevalence of treatment-resistant psychoses in the community: A naturalistic study
P50
Q30236016-BC732CCF-E5AC-41C6-B689-73658B393548Q35884165-8541BC97-5169-492A-8DDF-753D6DCB2520Q36992316-DEFED61E-3334-49E9-9DA1-B759FB54A6E9Q36992322-523A6D55-4353-402E-A227-48798DBEAE8EQ38247122-01F10A2B-79D2-4022-8A71-346E30545319Q38762872-4DECDFAB-686E-4B05-98A9-9ADB9B2DC327Q38976291-2210D00C-4CEA-4E44-A691-7B00230F4320Q43578699-27E9A5A7-569D-41F3-B105-3B8B11C85412Q45172062-A40E6C8E-9DDE-48D3-8D57-E4063749F532Q47120840-25CC3462-5759-4B6E-8376-924B69BD9CF4Q47560455-7A1896C6-1FED-477A-8B86-D923AA3C25F0Q50192659-1B861908-32AE-413E-8847-9A5B714FAA94Q50561922-518A2AC7-E4C3-41E2-902A-4160955E3B27Q53808719-61E8ED8B-0F72-4959-969E-90AA4F4D72B8Q58589435-23AFAD34-2A77-404C-939D-55B0325507A4Q58600003-8C7B00D3-D818-4C94-BBF0-42C4D49B7BB7Q58604458-3810AD37-0EC4-491A-8AFF-6E4CECCC43FAQ58793943-B1FC98B0-8213-4B76-B5FE-59A200D57BC8Q59743910-5D8EDDF8-3BC5-4C48-AB6F-2CC5855943B8Q60644119-57A73176-DDAC-42CF-A1E4-9314968C5397Q64085157-75C08ECB-0AE4-4CCD-BEF2-F088FA267FFAQ83227219-FB29B50A-27A9-4EFE-8378-1164070BE04FQ83231320-6DB8D545-6C7D-43B0-89D6-0504437E1F7AQ88618985-FD2C56E1-FF9C-42FB-BC47-71CD4E272BF8Q90185131-497F162A-FEC7-49AF-9E73-8F0E121172DCQ90679372-D455956D-3961-4E56-B2B3-D53EB3F18BB5Q90748306-65E8553E-4426-4351-8B56-88D70CC491EFQ90927588-F5B6FCAF-2381-452E-AF0B-36D40E05C1E8Q91001850-F816BC1D-7D65-4156-948E-24935B41D550Q91234986-2659E186-7FFC-4B48-B886-00AA33BA63F3Q91442157-32D35BAE-225A-438B-80B2-0C192D1DBA69Q91564771-180146FC-0A8E-47DA-8E16-C939D13FA62BQ91830177-315436E5-4F92-4DC1-B94E-8CFC20EEC8B5Q92027281-6B56050C-B016-43E8-AE52-8C6E945A339EQ92149111-4958A1AA-E50F-4A65-8601-70ACA43BF7A2Q92533020-343D4976-3294-4FD6-9CA6-542BA680657FQ92549251-5A0050CB-8668-4C0C-A606-CE43A0EB1E54Q92564640-FC30D1B2-7C18-45D2-B4B3-440F4B93C4E9Q93023627-654D34E0-4070-408D-BAA1-618C08264F0CQ93039785-4656C21B-8FEA-4A76-BB2A-1D2798C3DAA3
P50
description
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
Robert McCutcheon
@ast
Robert McCutcheon
@en
Robert McCutcheon
@es
Robert McCutcheon
@nl
type
label
Robert McCutcheon
@ast
Robert McCutcheon
@en
Robert McCutcheon
@es
Robert McCutcheon
@nl
prefLabel
Robert McCutcheon
@ast
Robert McCutcheon
@en
Robert McCutcheon
@es
Robert McCutcheon
@nl
P106
P1153
55681272600
P31
P496
0000-0003-1102-2566